173 related articles for article (PubMed ID: 6234253)
1. Molecular mechanism of fibrinolysis--a system involved with malignant cells.
Cederholm-Williams SA
Invasion Metastasis; 1981; 1(2):85-98. PubMed ID: 6234253
[No Abstract] [Full Text] [Related]
2. [The regulation of fibrinolysis].
Matsuo O
Nihon Rinsho; 1989 Apr; 47(4):739-45. PubMed ID: 2526261
[No Abstract] [Full Text] [Related]
3. [Extrinsic plasminogen activator: molecular properties and potential value as a new thrombolytic agent].
Collen D
Verh K Acad Geneeskd Belg; 1982; 44(5-6):295-305. PubMed ID: 6223460
[No Abstract] [Full Text] [Related]
4. Fibrinolysis: molecular mechanism and pathophysiological aspects.
Lijnen HR
Sangre (Barc); 1984; 29(4-C):755-61. PubMed ID: 6240123
[No Abstract] [Full Text] [Related]
5. [Mechanism of fibrinolysis (review of the literature)].
Kovalenko AN
Vrach Delo; 1983 Jan; (1):10-5. PubMed ID: 6223445
[No Abstract] [Full Text] [Related]
6. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
Marder VJ; Francis CW
Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
[No Abstract] [Full Text] [Related]
7. Regulation of fibrinolysis - recent developments.
Collen D
Prog Clin Biol Res; 1981; 72():221-8. PubMed ID: 6461014
[No Abstract] [Full Text] [Related]
8. Biological role of fibrinolysis.
Davidson JF; Walker ID
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():1-4. PubMed ID: 6448868
[No Abstract] [Full Text] [Related]
9. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
Sakata Y; Aoki N
J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanisms of thrombolytic therapy].
Lijnen HR; Collen D
Haemostasis; 1986; 16 Suppl 4():3-15. PubMed ID: 2945768
[No Abstract] [Full Text] [Related]
11. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
12. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
Andreenko GV
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
[TBL] [Abstract][Full Text] [Related]
13. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
Páramo JA; Collen D
Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
[No Abstract] [Full Text] [Related]
14. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.
Lijnen HR; Collen D
Semin Thromb Hemost; 1982 Jan; 8(1):2-10. PubMed ID: 6460318
[No Abstract] [Full Text] [Related]
15. [Blood coagulation mechanism from the viewpoint of molecular biochemistry].
Hashimoto S; Asai K
Rinsho Byori; 1985 Sep; 33(9):957-9. PubMed ID: 2934563
[No Abstract] [Full Text] [Related]
16. [Therapeutic advances against thromboembolic disease: II. The use of tissue fibrinolysis activator as a thrombolytic agent].
Rueda F; Félez J
Sangre (Barc); 1984; 29(4-A):429-48. PubMed ID: 6390755
[No Abstract] [Full Text] [Related]
17. The biological role of fibrinolysis.
Davidson JF; Walker ID
Adv Exp Med Biol; 1984; 164():229-34. PubMed ID: 6538057
[No Abstract] [Full Text] [Related]
18. Plasminogen activators: pharmacology and therapy.
Holden RW
Radiology; 1990 Mar; 174(3 Pt 2):993-1001. PubMed ID: 2137641
[TBL] [Abstract][Full Text] [Related]
19. [Role of plasminogen binding site of alpha 2-plasmin inhibitor on the initiation and regulation of fibrinolysis].
Iwamoto M; Sugiyama N
Rinsho Byori; 1989 Apr; Spec No 81():118-25. PubMed ID: 2526883
[No Abstract] [Full Text] [Related]
20. [Modern concepts of the hemostatic and fibrinolytic systems].
Andreenko GV
Klin Med (Mosk); 1974 Apr; 52(4):13-23. PubMed ID: 4282102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
